The Impact of Chronic Kidney Disease and Short-Term Treatment with Rosiglitazone on Plasma Cell-Free DNA Levels

Patients with chronic kidney disease (CKD) are at increased risk of cardiovascular disease. Circulating free nucleic acids, known as cell-free DNA (cfDNA), have been proposed as a novel biomarker of cardiovascular risk. The impact of renal impairment on cfDNA levels and whether cfDNA is associated w...

Descripción completa

Detalles Bibliográficos
Autores principales: McGuire, Amanda L., Urosevic, Nadia, Chan, Doris T., Dogra, Gursharan, Inglis, Timothy J. J., Chakera, Aron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211161/
https://www.ncbi.nlm.nih.gov/pubmed/25371664
http://dx.doi.org/10.1155/2014/643189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211161/
https://www.ncbi.nlm.nih.gov/pubmed/25371664
http://dx.doi.org/10.1155/2014/643189

Ejemplares similares